stacey globalconference publication 2015accpissue1ptpv2

8
A CCP’s highest awards will be presented during the Awards and Recognition Ceremony, set for 9 a.m. – noon today in Con- tinental Ballrooms 4 and 5. Events also include the introduction of new ACCP Fellows and messages from the outgoing and incoming ACCP presidents. Honors to be presented include the New Clinical Practitioner Award, New Educator Award, New Inves- tigator Award (and Lecture), ACCP Education Award, ACCP Clinical Practice Award, ACCP Russell R. Miller Award, Paul F. Parker Medal for Distinguished Service to the Pro- fession of Pharmacy, and Therapeu- tic Frontiers Lecture Award. ACCP New Clinical Practitioner Award The ACCP New Clinical Practi- tioner Award honors outstanding con- tributions to the health of patients, the practice of clinical pharmacy, or both. The 2015 award winner, Megan E. Musselman, Pharm.D., M.S., BCPS, is a clinical pharmacy specialist in emergency medicine/critical care at North Kansas City Hospital in Kansas City, Missouri. She also serves as a clinical instructor at the University of Kansas School of Pharmacy. In her current position, Dr. Musselman is Morning Ceremonies Will Honor National Award Winners responsible for establishing and ex- tending clinical pharmacist services in both intensive care and emergency medicine settings. Her nominators credit her with de- veloping or revamping several pro- cesses, including TPA administration during ischemic stroke, intranasal medication administration proto- cols, and an ED procedural sedation guideline, as well as improving phar- macist attendance at both pediatric and adult codes by increasing staff training and comfort levels. Dr. Musselman is also heavily involved with interdisciplin- ary teams on facil- ity-wide initiatives to ensure the safe and appropriate use of agents to reverse novel oral anticoagulants, identify and treat pa- tients with sepsis as early as possible, and streamline therapy for patients with pain, agitation, and delirium. Dr. Musselman has published sev- en papers in peer-reviewed journals and has cowritten two book chapters. Her work has been presented at na- tional meetings such as the American College of Emergency Physicians Research Forum, the North American Congress of Clinical Toxicology, and the ACCP Spring Practice and Re- search Forum. ACCP New Educator Award The 2015 recipient of the ACCP New Educator Award is Brent N. Reed, Pharm.D., BCPS (AQ Car- diology), an assistant professor in the Department of Pharmacy Prac- tice and Science at the University of Maryland School of Pharmacy and a clinical pharmacy specialist on the advanced heart failure service at the University of Maryland Medical Cen- ter in Baltimore, Maryland. He also serves as the program director for the institution’s PGY2 cardiology phar- macy practice residency program. The ACCP New Educator Award recognizes outstanding contribu- tions to the discipline of teaching and to the education of health care practitioners. Dr. Reed has excelled in both didactic and experiential set- tings, teaching required and elective courses across the curriculum and serving as an exceptional preceptor for students and residents. As course manager for the School of Pharmacy’s advanced heart fail- ure practice rotation for P4 students and PGY1 and PGY2 residents, Dr. Reed’s teaching integrates the “flipped classroom” technique in which learners complete didactic work independently in preparation for active learning in the classroom or rotation. Using this method in the ad- vanced heart fail- ure rotation, he developed a list of key concepts to accompany the assigned readings and a required series of short videos. On pre- senting clinic, a quick quiz assess- es learning and ensures that pre-assigned work has been completed. Dr. Reed asks learners to keep a daily “learning log” that documents knowledge acquired and that includes literature citations. He is also credited with developing an innovative rubric that makes performance assessment very clear to students. In addition to his teaching, Dr. Reed has published 13 papers in peer-reviewed journals, cowritten three book chapters, and presented at national professional and scientific meetings. Parker Medalist to Speak Today R obert L. Talbert, Pharm.D., FCCP, BCPS, is the 2015 re- cipient of the College’s Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy. He will accept the medal and deliver a brief address during the ACCP Awards and Recognition Ceremony this morning. Dr. Talbert has been a leader in clin- ical pharmacy practice, education, and research for more than 3 decades. In making its selection, the Parker Medal Robert L. Talbert, Pharm.D., FCCP, BCPS Continued on Page 8 2015 ACCP Global Conference News ® Hilton San Francisco Union Square San Francisco, California October 17–21, 2015 ISSUE 2 SUNDAY, OCT. 18 #ACCPGC15 Sunday Highlights Awards and Recognition Ceremony (8 a.m.-Noon) Residency and Fellowship Forums (8 a.m., 10 a.m., and 1 p.m.) Global Advancement of Clinical Pharmacy Practice (1:30–3 p.m.) Business and Town Hall Meeting (2:30–4:15 p.m.) Global Development of Clinical Pharmacy Education (3:15-4:45 p.m.) Clinical Pharmacy Challenge Semifinals (4:30–5:45 p.m.) Opening Reception and Game Night (6–9 p.m.) T oday’s events will be wide-rang- ing as Global Conference at- tendees hear details of a major research grant award and take part in a “Hollywood Game Night” fundraiser for the Research Institute (RI). Business and Town Hall The ACCP Business and Town Hall Meeting is scheduled for 2:30–4:15 p.m. in Continental Ballrooms 4 & 5. Reports from ACCP Board of Regents President Judith Jacobi and Treasur- er Bradley Phillips will be followed by updates from the Nominations Com- mittee, Government and Professional Affairs, ACCP PAC, Pharmacotherapy, and ACCP Research Institute. A highlight of the 3:15 p.m. Town Hall portion of the meeting will be a presen- tation of a $2.4 million project to study the impact of comprehensive medica- tion management (CMM) in contem- porary primary care medical practices. The University of North Carolina’s Es- helman School of Pharmacy (UNC) will study the impact of implementing CMM in contemporary primary care medical practices. Collaborating with UNC on this project are the Alliance for Inte- grated Medication Management, the American Academy of Family Physi- cians National Research Network, and the University of Minnesota College of Pharmacy. The collaborators will address how CMM can be implemented and sus- tained in real-world primary care med- ical practices, including which patients and populations within primary care practices benefit the most, how medi- cal practices can deliver CMM most ef- fectively, and what are the contributions of the clinical pharmacist to clinical and economic performance metrics. Opening Reception The day’s events conclude with fun and relaxation at the Opening Reception, set for 6–9 p.m. in the Yosemite Room. ACCP and the RI will host a live version of NBC’s popular “Hollywood Game Night.” As teams of four compete in a series of party games, meeting at- tendees can match wits and skills with colleagues, or just enjoy hors d’oeu- vres and refreshments while cheering others on to victory. The evening’s fun will benefit the RI in its mission to advance pharmacother- apy through support and promotion of research, training, and education. All donations made during this event will go to support the RI’s research initiatives. $2.5 Million Grant Award, Fundraiser Top Today’s Agenda Continued on Page 2 Dr. Musselman Dr. Reed

Upload: stacey-bortlik-hodgsonpharmdcphrphprsmtm

Post on 12-Apr-2017

56 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Stacey GlobalConference Publication 2015ACCPISSUE1PTPv2

ACCP’s highest awards will be presented during the Awards and Recognition Ceremony,

set for 9 a.m. – noon today in Con-tinental Ballrooms 4 and 5. Events also include the introduction of new ACCP Fellows and messages from the outgoing and incoming ACCP presidents.

Honors to be presented include the New Clinical Practitioner Award, New Educator Award, New Inves-tigator Award (and Lecture), ACCP Education Award, ACCP Clinical Practice Award, ACCP Russell R. Miller Award, Paul F. Parker Medal for Distinguished Service to the Pro-fession of Pharmacy, and Therapeu-tic Frontiers Lecture Award.

ACCP New Clinical Practitioner Award

The ACCP New Clinical Practi-tioner Award honors outstanding con-tributions to the health of patients, the practice of clinical pharmacy, or both. The 2015 award winner, Megan E. Musselman, Pharm.D., M.S., BCPS, is a clinical pharmacy specialist in emergency medicine/critical care at North Kansas City Hospital in Kansas City, Missouri. She also serves as a clinical instructor at the University of Kansas School of Pharmacy. In her current position, Dr. Musselman is

Morning Ceremonies Will Honor National Award Winnersresponsible for establishing and ex-tending clinical pharmacist services in both intensive care and emergency medicine settings.

Her nominators credit her with de-veloping or revamping several pro-cesses, including TPA administration during ischemic stroke, intranasal medication administration proto-cols, and an ED procedural sedation guideline, as well as improving phar-macist attendance at both pediatric and adult codes by increasing staff training and comfort levels. Dr. Musselman is also heavily involved with interdisciplin-ary teams on facil-ity-wide initiatives to ensure the safe and appropriate use of agents to reverse novel oral anticoagulants, identify and treat pa-tients with sepsis as early as possible, and streamline therapy for patients with pain, agitation, and delirium.

Dr. Musselman has published sev-en papers in peer-reviewed journals and has cowritten two book chapters. Her work has been presented at na-tional meetings such as the American College of Emergency Physicians

Research Forum, the North American Congress of Clinical Toxicology, and the ACCP Spring Practice and Re-search Forum.

ACCP New Educator AwardThe 2015 recipient of the ACCP

New Educator Award is Brent N. Reed, Pharm.D., BCPS (AQ Car-diology), an assistant professor in the Department of Pharmacy Prac-tice and Science at the University of Maryland School of Pharmacy and a clinical pharmacy specialist on the advanced heart failure service at the University of Maryland Medical Cen-ter in Baltimore, Maryland. He also serves as the program director for the institution’s PGY2 cardiology phar-macy practice residency program.

The ACCP New Educator Award recognizes outstanding contribu-tions to the discipline of teaching and to the education of health care practitioners. Dr. Reed has excelled in both didactic and experiential set-tings, teaching required and elective courses across the curriculum and serving as an exceptional preceptor for students and residents.

As course manager for the School of Pharmacy’s advanced heart fail-ure practice rotation for P4 students and PGY1 and PGY2 residents, Dr. Reed’s teaching integrates the

“flipped classroom” technique in which learners complete didactic work independently in preparation for active learning in the classroom or rotation. Using this method in the ad-

vanced heart fail-ure rotation, he developed a list of key concepts to accompany the assigned readings and a required series of short videos. On pre-senting clinic, a quick quiz assess-es learning and

ensures that pre-assigned work has been completed.

Dr. Reed asks learners to keep a daily “learning log” that documents knowledge acquired and that includes literature citations. He is also credited with developing an innovative rubric that makes performance assessment very clear to students.

In addition to his teaching, Dr. Reed has published 13 papers in peer-reviewed journals, cowritten three book chapters, and presented at national professional and scientific meetings.

Parker Medalist to Speak Today

Robert L. Talbert, Pharm.D., FCCP, BCPS, is the 2015 re-cipient of the College’s Paul F.

Parker Medal for Distinguished Service to the Profession of Pharmacy. He will accept the medal and deliver a brief address during the ACCP Awards and Recognition Ceremony this morning.

Dr. Talbert has been a leader in clin-ical pharmacy practice, education, and research for more than 3 decades. In making its selection, the Parker Medal

Robert L. Talbert, Pharm.D., FCCP, BCPS

Continued on Page 8

2015 ACCP Global Conference News

®

Hilton San Francisco Union Square San Francisco, California October 17–21, 2015

ISSUE 2SUNDAY, OCT. 18

#ACCPGC15

Sunday Highlights• Awards and Recognition Ceremony (8 a.m.-Noon)

• Residency and Fellowship Forums (8 a.m., 10 a.m., and 1 p.m.)

• Global Advancement of Clinical Pharmacy Practice (1:30–3 p.m.)

• Business and Town Hall Meeting (2:30–4:15 p.m.)

• Global Development of Clinical Pharmacy Education (3:15-4:45 p.m.)

• Clinical Pharmacy ChallengeSemifinals (4:30–5:45 p.m.)

• Opening Reception and Game Night (6–9 p.m.)

Today’s events will be wide-rang-ing as Global Conference at-tendees hear details of a major

research grant award and take part in a “Hollywood Game Night” fundraiser for the Research Institute (RI).

Business and Town HallThe ACCP Business and Town Hall

Meeting is scheduled for 2:30–4:15 p.m. in Continental Ballrooms 4 & 5. Reports from ACCP Board of Regents President Judith Jacobi and Treasur-er Bradley Phillips will be followed by updates from the Nominations Com-mittee, Government and Professional Affairs, ACCP PAC, Pharmacotherapy, and ACCP Research Institute.

A highlight of the 3:15 p.m. Town Hall portion of the meeting will be a presen-tation of a $2.4 million project to study the impact of comprehensive medica-tion management (CMM) in contem-porary primary care medical practices. The University of North Carolina’s Es-helman School of Pharmacy (UNC) will study the impact of implementing CMM in contemporary primary care medical practices. Collaborating with UNC on this project are the Alliance for Inte-grated Medication Management, the American Academy of Family Physi-

cians National Research Network, and the University of Minnesota College of Pharmacy.

The collaborators will address how CMM can be implemented and sus-tained in real-world primary care med-ical practices, including which patients and populations within primary care practices benefit the most, how medi-cal practices can deliver CMM most ef-fectively, and what are the contributions of the clinical pharmacist to clinical and economic performance metrics.

Opening ReceptionThe day’s events conclude with fun

and relaxation at the Opening Reception, set for 6–9 p.m. in the Yosemite Room.

ACCP and the RI will host a live version of NBC’s popular “Hollywood Game Night.” As teams of four compete in a series of party games, meeting at-tendees can match wits and skills with colleagues, or just enjoy hors d’oeu-vres and refreshments while cheering others on to victory.

The evening’s fun will benefit the RI in its mission to advance pharmacother-apy through support and promotion of research, training, and education. All donations made during this event will go to support the RI’s research initiatives.

$2.5 Million Grant Award, Fundraiser Top Today’s Agenda

Continued on Page 2

Dr. Musselman

Dr. Reed

Page 2: Stacey GlobalConference Publication 2015ACCPISSUE1PTPv2

2 • Sunday, October 18, 2015 ACCP GLOBAL CONFERENCE NEWS

AwardsContinued from page 1

ACCP New Investigator AwardThe ACCP New Investigator Award

recognizes a member who has signifi-cantly affected clinical pharmaceutical science. The 2015 awardee, Steven M. Smith, Pharm.D., MPH, BCPS, is an assistant professor of pharmacy and medicine, Departments of Phar-macotherapy & Translational Research and Community Health & Family Med-icine, in the Colleges of Pharmacy and Medicine at the University of Florida in Gainesville, Florida.

Dr. Smith’s research focuses on hy-pertension with an emphasis on treat-ment-resistant disease. He has served as first or senior author for 17 papers

and 11 book chap-ters, with work in high-impact journals such as the Jour-nal of the American Society of Hyper-tension, Journal of Hypertension, Jour-nal of the American Heart Association, American Journal of Hypertension, and

Journal of Clinical Hypertension.Letters supporting his nomination

describe Dr. Smith as an “accomplished clinician-scientist-educator and a lead-er in cardiovascular population-based health services research and policy” with a national reputation in resistant hypertension, having published seven original research papers in this area and presented related work at meet-ings of the American Heart Association, the American Society of Hypertension, ACCP, and ASHP.

Julie Johnson, dean and distin-guished professor at the University of Florida College of Pharmacy, noted that Dr. Smith has received more than $375,000 in research funding as prin-cipal or co-principal investigator and more than $500,000 in overall funding as a junior faculty member – all in slight-ly more than 3 years since completing his postdoctoral work. “Notably, he was the ACCP nominee (and recipient) of the Institute of Medicine Anniversary Pharmacy Fellowship (2014–2016), which positions him to garner substan-tial influence through his participation in IOM committees,” Dr. Johnson said. “He also presented two abstracts at the 2014 Scientific Sessions of the Ameri-can Heart Association … a substantial accomplishment as only about 30% of submitted abstracts are accepted.”

Dr. Smith will deliver the New Inves-tigator Award lecture during this morn-ing’s ceremony.

ACCP Education AwardThe ACCP Education Award recog-

nizes an ACCP member for substantial and outstanding contributions to clinical pharmacy education at either the un-dergraduate or the postgraduate level. The 2015 awardee, Kelly R. Ragucci, Pharm.D., FCCP, BCPS, CDE, is pro-fessor and chair, Department of Clinical Pharmacy and Outcomes Science, at the South Carolina College of Pharma-cy’s Medical University of South Caroli-na (MUSC) campus.

Writing in support of her nomination, Dr. Nicole Culhane, associate professor and director of experiential programs at the Notre Dame of Maryland University School of Pharma-cy, said Dr. Ragucci “… has dedicated her professional life to teaching and mentoring over 100 student pharmacists and residents and advocating for their best interests.” Dr. Culhane also noted Dr. Ragucci’s many teaching honors, which include eight Professor of the Year awards since 2003 and Preceptor of the Year in 2006.

As a coinvestigator, Dr. Ragucci has received a large IPE grant from the Jo-siah Macy Jr. Foundation to study vir-tual interprofessional learning. She and her MUSC colleagues are garnering wide recognition for their contributions and for presenting their IPE model at national conferences.

Dr. Ragucci has served as an inves-tigator on 27 research grants, published more than 50 papers in peer-reviewed journals, and presented extensively at professional and scientific meetings (in-cluding those of ACCP). She has served as secretary and chair of ACCP’s Ambula-tory Care PRN and as a member or chair of numerous ACCP committees. She was elected as an ACCP Fellow in 2005.

ACCP Clinical Practice AwardThe ACCP Clinical Practice Award is

given to a member who has made sub-stantial and outstanding contributions to clinical pharmacy practice. The selec-tion criteria include exceptional leader-ship in developing and providing inno-vative clinical pharmacy services.

The 2015 recipient, Roland N. Dick-erson, Pharm.D., FCCP, FACN, FASHP, FCCM, BCNSP, is a professor of clini-cal pharmacy practice at the University of Tennessee Health Sciences Center College of Pharmacy in Memphis, Ten-nessee. For more than 20 years, Dr. Dickerson has provided leadership and coordination to the nutrition support ser-vice at Regional One Health (formerly, the Regional Medical Center of Mem-

phis). The support service provides care for critically ill patients, including those on the trauma, transplant, and oth-er medical/surgical intensive care ser-vices.

His nomination by Dr. Robert MacLar-en, critical care cli-nician and professor

at the University of Colorado Denver School of Pharmacy and Pharmaceu-tical Sciences, noted Dr. Dickerson’s guidance of dietitians, nurses, pharma-cists, and physicians in the manage-ment of enteral and parenteral nutrition, fluids and electrolytes/minerals, and various nutrition-related complications. “The primary teams have come to rely on the nutrition support service to direct these therapies,” Dr. MacLaren said. “I cannot think of another example in phar-macy practice where the pharmacist is

the director of a service so revered for its impact on patient care.”

Dr. Dickerson has authored more than 150 peer-reviewed papers and several book chapters, and presented at national and international professional and scientific meetings. In 2012 he be-came the first pharmacist to receive the prestigious Rhoads Lecture Award from the American Society for Parenteral and Enteral Nutrition. The award recognizes international contributions to the field of nutrition and metabolic support, as well as a career-long commitment to improv-ing the nutritional status of patients.

Dr. Dickerson serves as an editor for five journals, including the Journal of Parenteral and Enteral Nutrition, and has provided reviews for more than 30 journals. For ACCP, he has served on several committees and on many research award selection panels. Dr. Dickerson was recognized as an ACCP Fellow in 2003 and as a fellow of the So-ciety of Critical Care Medicine in 2013.

Russell R. Miller AwardThe Russell R. Miller Award, named

for the founding editor of the College’s journal, Pharmacotherapy, recognizes substantial contributions to the literature of clinical pharmacy, thereby advanc-ing both clinical pharmacy practice and rational pharmacotherapy. The 2015 award recipient, Howard L. McLeod, Pharm.D., FCCP, is medical director, DeBartolo Family Personalized Medi-cine Institute, at the Moffitt Cancer Cen-ter in Tampa, Florida.

Dr. McLeod has published almost 500 peer-reviewed manuscripts, 26 book chapters, and more than 300 ab-stracts. In her nom-ination, Dr. Vicki Ellingrod, the John Gideon Searle Pro-fessor of Clinical and Translational Pharmacy at the University of Michigan, described Dr. McLeod as an important contributor to the literature, a leader in oncology pharmacy, and at the forefront of the field of pharmacogenomics.

“He has been described as the ‘father’ of oncology pharmacogenomics,” Dr. Ellingrod said. “Five of his manuscripts have been cited over 400 times each, with his most highly cited manuscript re-ceiving more than 139 citations/year with a total of 1531. Very few clinical pharma-cists achieve research accomplishments that are so pervasive within the field.”

In his letter of support, Dr. Samuel Johnson, clinical pharmacy specialist in applied pharmacogenomics at Kaiser Permanente Colorado, noted that Dr. McLeod’s work has appeared in many publications that review the clinical and economic impact of pharmacogenom-ics, including the New England Journal of Medicine, Annals of Neurology, Jour-nal of Clinical Oncology, Lancet, Phar-macogenomics Journal, Clinical Phar-macology and Therapeutics, and Blood.

Dr. McLeod serves as an editorial board member for Biomarkers in Med-icine, Personalized Medicine, Phar-macogenetics and Genomics, and Pharmacogenomics. He serves as a re-viewer for prestigious journals including

Clinical Pharmacology and Therapeu-tics, Journal of the American Medical Association, Lancet, Nature Genetics, Nature Medicine, New England Journal of Medicine, and Science. His previous ACCP honors include the New Investi-gator Award in 2000, ACCP Fellow rec-ognition in 2004, and the ACCP Thera-peutic Frontiers Lecture Award in 2008.

Therapeutic Frontiers Lecture AwardAt 10:30 a.m., William Douglas Figg,

Pharm.D., MBA, will present the 2015 Therapeutic Frontiers Award Lecture, ti-tled “The National Cancer Institute’s Re-volving Door of Science: Bench to Bed-side and Back to the Bench.” The award recognizes an ACCP member or non-member for outstanding contributions to pharmacotherapeutics. Criteria include the broad acknowledgment that the re-cipient is considered to be at the leading edge of research in his or her field.

As senior investigator, section head, and deputy branch chief of the Molec-ular Pharmacology section within the Genitourinary Malig-nancies Branch and head of the Clinical Pharmacology Pro-gram at the Center for Cancer Research in the National Insti-tute of Health’s Na-tional Cancer Insti-tute (NCI) in Bethesda, Maryland, Dr. Figg has earned national and interna-tional recognition in the field of antican-cer drug development.

In her letter of support, NCI research scientist Dr. Cindy Chau noted that Dr. Figg’s work in anticancer drug develop-ment has an emphasis on anti-angiogen-ic compounds, which are essential for the growth, invasion, and metastasis of solid tumors. Inhibition of angiogenesis is a promising new strategy now recognized as the fourth modality of cancer treatment.

“His research (is) focused on under-standing the nature of angiogenesis in solid tumors (specifically prostate can-cer) and in translating basic science discoveries into clinical applications,” Dr. Chau said.

The in vitro and in vivo models devel-oped and optimized in Dr. Figg’s labo-ratory have assisted in screening novel angiogenesis inhibitors, selecting com-pounds for further development, and designing new agents to hit key targets in the angiogenic pathway, she said. “Dr. Figg has also devoted enormous efforts to understanding the biology of prostate cancer and developing treat-ments for metastatic CRPC.”

Dr. Figg has published more than 500 peer-reviewed manuscripts. He coedited Angiogenesis—An Integrative Approach from Science to Medicine, which is widely recognized as the au-thoritative text in the angiogenesis field. He has served as an editorial board member for journals such as Pharma-cotherapy, and as a manuscript review-er for publications such as the New En-gland Journal of Medicine.

Elected as a fellow of the American College of Clinical Pharmacology and as an ACCP Fellow, Dr. Figg’s many na-tional and international awards include the 2008 ACCP Russell R. Miller Award.

Dr. Figg

Dr. Ragucci

Dr. McLeod

Dr. Smith

Dr. Dickerson

Page 3: Stacey GlobalConference Publication 2015ACCPISSUE1PTPv2

Sunday, October 18, 2015 • 3 ACCP GLOBAL CONFERENCE NEWS

The Certified Geriatric Pharmacist credential is ideal for the

pharmacist who serves older adults.

Only one credential has been established to recognize pharmacists with expertise in the care of older adults and the provision of medication therapy management services to geriatric patients—the Certified Geriatric Pharmacist (CGP), administered by the Commission for Certification in Geriatric Pharmacy.

The CGP examination is computer-based and is offered at test centers around the United States and Canada. The examination is 150 multiple-choice questions, and is offered in four test windows throughout the year. A pharmacist must have a current pharmacist license with two years of experience to be eligible to take the examination.

Visit www.ccgp.org for more information.

“Like no time before, we have a tremendous amount of data at our fingertips. We have to

figure out how to use it. People are trying to do

that in innovative ways. In this economy, we’re all pushed to do more with less, so identifying ways to be more efficient and

demonstrate our value is more important

than ever.”

– Angela Smith, Pharm.D., BCPS, MHA

Data-driven decisions are affect-ing all areas of business. With the move to electronic health

records (EHRs), the same level of in-fluence is available for clinical admin-istration pharmacists.

As the Centers for Medicare & Medicaid Services (CMS) moves to stage 3 of its EHR incentive program in 2017, data available through health records are expected to im-prove care.

Metrics that mea-sure efficiency and manage department workflow can lead to improved pharmacy operations. Learning from two health sys-tems that have made significant strides in data-driven decisions will be the focus of the Clinical Administration PRN Focus Session. “Patient Monitoring Prioritization and Pro-ductivity Measurement to Grow and Sustain Pharmacy Services” will be from 1:30 to 3 p.m. Monday in Plaza Room A.

“Like no time before, we have a tre-mendous amount of data at our finger-tips,” said Angela Smith, Pharm.D., BCPS, MHA, director of pharmacy, North Carolina Department of Health

and Human Services, Division of State Operated Healthcare Facilities. Smith will moderate the discussion. “We have to figure out how to use it. People are trying to do that in innova-tive ways. In this economy, we’re all pushed to do more with less, so iden-tifying ways to be more efficient and demonstrate our value is more import-

ant than ever.”The topic has often

been considered for previous focus ses-sions. But the time was right now, thanks to the CMS push and the availability of EHRs, Smith said. Be-cause the PRN has pharmacists who have used EHR to improve their operations, “there was a lot of interest in seeing what they had done.”

Kyle H. Townsend, Pharm.D., BCPS, director of pharma-cy services, Billings Clinic in Montana, will discuss how the clinic

applies Lean Six Sigma principles to improve operations without sacrificing safety. The clinic has been ranked No. 1 for safety by Consumer Reports.

In his presentation “Departmental Excellence: Undiscovered Oppor-tunities and Metrics in Pharmacy,”

Townsend will show the results. Since beginning the process in 2008, the clinic has trained more than 600 staff and leadership in the basic principles of Lean Six Sigma. The clinic projects savings of $50 million between 2009 and June 2015.

The Lean Six Sigma principles fo-cus on reducing waste and improving processes by removing variations. To apply those broad principles to phar-macy, Townsend’s team developed a series of dashboards that provide a real-time snapshot into how the department is operating. Among the items monitored: pharmacist and tech productivity, stockouts, and expired drugs. Metrics are reviewed at month-ly meetings.

In the presentation “Clinical Prac-tice Innovation: Use of Productivity Dashboards in Electronic Health Re-cords to Direct Clinical Workflow,” Richard H. Parrish II, Ph.D., FCCP, BCPS, clinical practice leader, Phar-macy Perioperative Care, Alberta Health Services, Edmonton, will show how dashboards have been used to inform clinical decisions.

These decisions can be made on the basis of a variety of factors, from patient location to drug-specific factors to those tied to laboratory results. The dashboards can provide real-time in-

Clinical Administration PRN Looks for Ways to Improve Dataformation as well as retrospective data.

“You can tie metrics around the basic process of order dispensing,” Smith said. “Those are hard numbers. Clinical metrics are a little more diffi-cult to quantify. These presentations will show what metrics people are tracking and how they are measuring professional time. Electronic health records can be used to sift through the weeds and pull out triggers for things we need to act on more effi-ciently.”

Although each presentation will provide details on specific data sys-tems, Smith believes there will be some key takeaways, no matter which EHR system is in use.

“Pharmacists should be able to take some of this back to their facilities or be able to go to their developers and ask, ‘How can we integrate this? This metric is important or I want to pull my patients in this way and have daily re-ports.’ So that they can figure out how to integrate into their system.”

Data-driven decisions should not get in the way of the pharmacist’s ul-timate responsibility in delivering pa-tient care, Smith believes. “If we can do our job better, we can feed into the goal of the facility, which would be to deliver highest quality patient care as efficiently as possible.”

ACCP Is Looking for a Few Good Tweets

Join the Twitter conversation at the 2015 Global Conference by sharing meeting photos, news, and clinical insights and you may win a prize from ACCP!

A panel of judges will review each day’s posts using #ACCPGC15 and select the best Tweet of the Day! Daily winners may choose one of the following prizes:

Clinical Pharmacy in the United States: Transformation of a Profession

Nourishing the Soul of Pharmacy: Stories of Reflection

Resident Survival Guide

ACCP

CODES

$25 ACCP Gift Code to be used at the ACCP Bookstore

Tweet to Compete!

Page 4: Stacey GlobalConference Publication 2015ACCPISSUE1PTPv2

4 • Sunday, October 18, 2015 ACCP GLOBAL CONFERENCE NEWS

Learn more about the many ac-tivities of ACCP’s Research Institute (RI) and Pharmaco-

therapy journal at an Open House slated for 8–10 a.m., Tuesday, Oct. 20, in Continental Ballroom 4.

During these informal roundtable chats, representatives from Phar-macotherapy will be available to discuss special issues and manu-scripts of interest, how to become a reviewer, or the steps needed to join the journal’s Editorial Board. Addi-tional information for international authors and reviewers will also be available.

Staff from ACCP’s Prac-tice-Based Research Network (PBRN) and its Community Advi-sory Panel will have information about PBRN activities and ways that you can contribute to research that affects your own practice. Fac-ulty from the Focused Investigator Training (FIT) and Mentored Re-search Investigator Training (MeR-IT) programs can speak one-on-one about these investigator develop-ment programs.

Learn about the RI’s 2016 Fu-tures Grants Program, which sup-ports research projects submitted by student, trainee, and junior in-vestigators. The Open House is also a chance to network with various PRN groups or individual members and discuss research and scholar-ship ideas.

For a complete schedule of Open House events and a list of the ex-perts who will be available, check the 2015 Global Conference Meet-ing Guide.

Research Institute, Pharmacotherapy Schedule Information Session

Student pharmacists representing four schools will take part in the exciting live action semifinals of

the Clinical Pharmacy Challenge, set for 4:30 p.m. today in Continental Ball-rooms 4 & 5.

A total of 108 teams, each represent-ing a unique school or college of phar-macy, participated in this year’s compe-tition. After online rounds, eight teams advanced to live rounds of competition in San Francisco. These quarterfinalist teams were: South Carolina College of Pharmacy; Thomas Jefferson Uni-versity Jefferson College of Pharmacy; University of California, San Francisco School of Pharmacy; University of Iowa

Four Teams Left Standing in Clinical Pharmacy ChallengeCollege of Pharmacy; University of Min-nesota College of Pharmacy; Universi-ty of Oklahoma College of Pharmacy; University of Pittsburgh School of Phar-macy; and University of Utah College of Pharmacy.

These eight quarterfinal teams faced off yesterday at the Global Con-ference, answering items in each of the competition’s distinct segments: (1) trivia/lightning; (2) clinical case; and (3) Jeopardy-style.

Item content used in the Chal-lenge was developed and reviewed by an expert panel of clinical phar-macy practitioners and educators. The 2015 ACCP Clinical Pharmacy

Challenge Item-Author Panel was chaired by Sandra Benavides Cabal-lero, Pharm.D., FCCP, FPPAG.

Each team member advancing to the quarterfinal rounds receives a complimentary student full-meeting registration, an ACCP gift certificate for $125, and a certificate of recogni-tion. Challenge Finals are slated for 11 a.m. Monday, with the winners earning $1500 and the title of 2015 ACCP Clini-cal Pharmacy Challenge Champion.

More information on the Challenge and a listing of the teams that partici-pated in the four online rounds is avail-able at http://www.accp.com/stunet/index.aspx.

Page 5: Stacey GlobalConference Publication 2015ACCPISSUE1PTPv2

Sunday, October 18, 2015 • 5 ACCP GLOBAL CONFERENCE NEWS

Researchers from the United States and around the world will summa-rize their latest findings during

Scientific Paper Presentations slated for Monday and Tuesday mornings.

All are welcome to join the authors as they discuss their findings and practice recommendations. The ques-tion-and-answer format invites com-mentary on the implementation and impact of this important research.

International Presentations

Scientific papers presented Mon-day, Oct. 19, in Franciscan Ballrooms A&B include the following:

• 9:15 a.m. – Evaluation of a Col-laborative Care Model with Pharma-cist-Led Medication Reviews for Adults on Haemodialysis. By Hua Heng Mcvin Cheen, BSc(Pharm)(Hons), Singapore General Hospital, Singapore

• 9:40 a.m. – Impact of Pharma-cist-Involved Collaborative Care Model on Metabolic Control and Psychologi-cal Health of Patients with Uncontrolled Type 2 Diabetes: A Prospective, Multi-center, Randomized, Controlled Study. By Joyce Lee, Pharm.D., BCPS, BCACP, National University of Singa-pore, Singapore

• 10:05 a.m. – Adherence Assess-ment Techniques in Adolescents Re-ceiving a Protease Inhibitor Based Antiretroviral Therapy Treatment Reg-imen in a Resource Limited Setting. By Tinashe Mudzviti, BPharm(Hons), Uni-versity of Zimbabwe, Zimbabwe

• 10:30 a.m. – Impact of Polymor-phisms of the GGCX Gene on Main-tenance Warfarin Dose: Systematic

Review and Meta-analysis. By Jinhua Zhang, Ph.D., Fujian Medical Universi-ty Union Hospital, PR China

• 10:55 a.m. – Impact of NQO1 Variants on Stable Warfarin Doses in Korean Patients with Mechanical Car-diac Valves. By Jee-Eun Chung, M.S., Ewha Womans University, Seoul, South Korea

The best international papers will be selected by a team of judges that includes Vicki Ellingrod (chair), Ken-neth Cheung, Loai Saadah, and Paul C Wong.

U.S. Presentations

Scientific papers presented Tues-day, Oct. 20, in Continental Ballrooms 7–9 include the following:

• 10:15 a.m. – A Novel Reve-nue-Generating Pharmacy-Led Transi-tions of Care Program. By John Gums, Pharm.D., FCCP, University of Florida, Gainesville, Florida

• 10:40 a.m. – Burden of Out-of-pock-et Medication Cost in a Primary Care Setting and Development of a Clinical Service to Assist Patients with Accessing Medications. By Robyn Teply, Pharm.D., Creighton University, Omaha, Nebraska

• 11:05 a.m. – Genetics and Drug Response: Study on the Influence of Genetics in Individual Variations in Response to Oxycodone Use. By Na-tasha Anand, M.S., B.A., Proove Bio-sciences, Irvine, California

• 11:30 a.m. – Development and Evaluation of Pharmacogenomic Clin-ical Decision Support within a Large Healthcare System. By J. Kevin Hicks, Pharm.D., Ph.D., Cleveland Clinic,

U.S., International Clinical Pharmacists Share Research Findings

ment to practice transformation and the College’s longer-term strategic goals.

• Innovations in Practice Technol-ogy (9:15–10:45 a.m. Monday, Oct. 19). New practice technologies are available that may expand or enhance patient care. This session will describe new practice technologies and their actual and potential roles in delivering patient care. The session will incorpo-rate evidence as well as clinician ex-perience on the effectiveness of new technologies and will forecast potential roles of technologies within the prac-tice of clinical pharmacy.

• Clinical Administration PRN Focus Session – Patient Monitor-ing Prioritization and Productivity Measurement to Grow and Sustain Pharmacy Services (1:30–3:00 p.m. Monday, Oct. 19). As quality outcomes become increasingly more important in the evolving world of health care,

health systems and pharmacy depart-ments must identify key metrics that drive efficiency and manage work-flow, in addition to capturing clinical work and identifying patients in need of a clinical pharmacist’s intervention. This session will discuss opportunities and metrics in pharmacy and explain how to use productivity dashboards in the electronic health records to drive changes in pharmacy practice.

• Advancing Clinical Pharmacy Practice: Innovative Models (10:15–11:45 a.m. Tuesday, Oct. 20). Practice innovation is a major focus in the cur-rent health care environment. This ses-sion will describe the impact of clinical pharmacists on the implementation of innovative health care practices in var-ious settings. The session will specif-ically showcase projects recognized through the Centers for Medicare & Medicaid Innovation Awards and oth-er national awards where pharmacists play a major role.

• Adult Medicine PRN and Am-bulatory Care PRN Focus Session – Transitions of Care Management: Best Practices (1:30–3:00 p.m. Tues-day, Oct. 20). Patient movement across health care settings introduces risk of medication and communication errors,

Upcoming Sessions Aid Practice Advancement, Transformation

and clinical pharmacists on interpro-fessional teams can assist in bridging these dangerous gaps. In this session, learn how to put systematic transition principles into practice from both inpa-tient and ambulatory care experts, as well as how to integrate trainees into the service.

• Ambulatory Care PRN Focus Session – Billing Practices in Ambu-latory Care Pharmacy: Developing, Implementing, and Sustaining Ideal Models (3:15–4:45 p.m. Tuesday, Oct. 20). As health care systems evolve, so do compensation models to support the sustainability and growth of clinical services provided to patients. Attend this session to learn about the best practices, challenges, and realities of implementing both well-known and emerging billing methods to ensure that your clinical pharmacy practice ex-cels in providing CMM.

As health care systems evolve, so do compensation models to support the sustainability and

growth of clinical services provided to patients.

Patient movement across health care settings introduces risk of medication and communication

errors, and clinical pharmacists on interprofessional teams can assist in bridging these dangerous gaps.

Cleveland, Ohio• 11:55 a.m. – Levonorgestrel Im-

plant + Efavirenz-Based Antiretroviral Therapy: Unintended Pregnancies and Associated Pharmacokinetic Data. By Kimberly K. Scarsi, Pharm.D., M.Sc.,

University of Nebraska Medical Center, Omaha, Nebraska

Each of the U.S. best papers will be accompanied by an invited guest commentary.

Learn more about becoming a journal contributor or the RI programs such

as the Practice-Based Research Network (PBRN), Focused Investigator

Training (FIT), Mentored Research Investigator Training (MeRIT), and

Futures Grants Program.

OPEN HOUSE8-10 a.m. Tuesday, Oct. 20

Continental Ballroom 4

The Journal of Human Pharmacology and Drug Therapy

A number of Global Conference sessions support ACCP’s priority of clinical practice advancement

and practice transformation. Scheduled events include the following:

• Keynote Address: Measuring Quality in Patient-Centered Care – Challenges and Opportunities (7:45–9:00 a.m. Monday, Oct. 19). “Measur-ing Quality in Patient-Centered Care – Challenges and Opportunities” will be presented by Michael S. Barr, M.D., MBA, FACP, Executive Vice President, Research, Performance Measurement and Analysis, National Committee for Quality Assurance.

• ACCP Advocacy and Practice Transformation: Updates on ACCP’s Medicare Initiative (9:15–11:15 a.m. Monday, Oct. 19). Learn about the progress ACCP has made in its legis-lative initiative to secure Medicare Part B coverage for CMM services provid-ed by qualified clinical pharmacists as members of the patient’s health care team. Hear the latest from Capitol Hill and the outlook for 2016. Find out how you can get involved through grass-roots advocacy and the ACCP-PAC to help move this initiative forward in Congress. Understand how our work in Washington relates to ACCP’s commit-

Page 6: Stacey GlobalConference Publication 2015ACCPISSUE1PTPv2

6 • Sunday, October 18, 2015 ACCP GLOBAL CONFERENCE NEWS

HIV infection has always been a multifaceted disease. As pa-tients live longer, and as more

treatment options become available, the layers of complexity only increase.

It is enough to cause a practitioner concern – especially when care hap-pens outside the standard HIV treat-ment setting. Demystifying some of those concerns is the goal of the HIV PRN focus session “HIV Across the Ages,” set for 3:15 p.m. Tuesday, Oct. 20, in Plaza Room B.

The session centers on a new un-derstanding of treatment for pregnant women; this treatment must balance the goals of maternal well-being while preventing transfer to the fetus. It will also explore the treatment of pediatric patients, who bring their own unique challenges. Also discussed will be the growing number of patients with HIV who are older than 50 and include oth-er comorbid disease states.

“We wanted to focus on managing the patient from start to finish, basical-ly from inception until the end,” said Melissa Badowski, Pharm.D., BCPS, AAHIVP, clinical assistant professor, Section of Infectious Disease Phar-macotherapy, University of Illinois at Chicago, College of Pharmacy, Illinois Department of Corrections HIV Tele-medicine, Chicago. “The adult popu-lation is the majority that we deal with. There are these special populations throughout HIV that we wanted to fo-cus on.”

Take a

Coffee Break

Meet the Series Editors from PSAP and the other ACCP Self-Assessment Programs

7:30 –9:30 a.m. Tuesday, Oct. 20, in the On-Site Bookstore

with the Editors

Brookie M. Best, Pharm.D., profes-sor of clinical pharmacy and pediatrics and associate dean for admissions and outreach, Skaggs School of Phar-macy and Pharmaceutical Sciences and School of Medicine-Rady Chil-dren’s Hospital-San Diego, will pres-ent a session on “Perinatal Preven-tion, Transmission, and Management of HIV.” The session will cover the pharmacokinetic characteristics of an-tiretroviral therapy during pregnancy as well as treatment regimens for peri-natal prevention and management.

“There are antiretroviral agents that are newly considered for managing the pregnant patient,” Badowski said. “With the advent of preexposure pro-phylaxis, there’s been a lot of buzz around that…. [But] unless you’re involved in the treatment, you may not know the goals of that therapy or the pharmacokinetic changes during

pregnancy with antiretroviral therapy.”Diana Yu, Pharm.D., BCPS, clinical

specialist, infectious diseases at Chil-dren’s Mercy Hospital in Kansas City, Mo., will explore treatment options for “Pediatric Management of HIV.” Re-search shows that the risk of HIV pro-gression is inversely proportional to the age of the child and that younger children are at greatest risk of AIDS or death.

Combination antiretroviral treat-ment adherence is key. Young chil-dren are more dependent on others to provide medication, and a lack of pal-atability can lead to a child’s refusal to take these agents. Moreover, for older children, particularly those who were infected in utero, regimen fatigue can set in.

“Pediatric patients can be the hard-est population to treat, because you are not only treating the patient, but also the caregiver,” Badowski said. “The caregivers have to be competent and have the knowledge to educate the children as well as provide the care and medication for the children.”

At the opposite end of the spectrum are older patients. Badowski cites a 2015 study showing that more than half of patients with HIV were older than 50. This is a relatively new wrin-kle because therapies have extend-ed the life span. But this means that diseases typically seen in older adults – like cardiovascular disease or bone mineral density issues – are present together with HIV. Moreover, “some

of these [HIV] medications can have potential side effects, and some of the pharmacokinetic factors may change in the elderly,” Badowski said.

Amie Taggart Blaszczyk, Pharm.D., BCPS, CGP, associate professor and division head, geriatrics, Texas Tech University, Dallas, will address treat-ment of this population in “HIV in the Elderly.”

As if the treatment of these vast-ly different patients weren’t complex enough, an increasing number may seek treatment with a general practi-tioner or non-HIV specialist, such as a pediatrician or gynecologist. “While most of us feel comfortable dealing with those populations, they are still going to come in the primary care clin-ic or a women’s clinic, where they may not be totally comfortable in dealing with HIV patients. It’s not just a talk for HIV specialists,” Badowski said.

HIV PRN Session Explores Treatment Challenges Across the Age Spectrum

“We wanted to focus on managing the patient from start to finish, basically from inception until

the end. The adult population is the majority that we deal with.

There are these special populations throughout HIV that we wanted to focus on.”

– Melissa Badowski, Pharm.D., BCPS, AAHIVP

“Pediatric patients can be the hardest population to treat,

because you are not only treating the patient, but also the caregiver.

The caregivers have to be competent and have the knowledge

to educate the children as well as provide the care and

medication for the children.”

– Melissa Badowski, Pharm.D., BCPS, AAHIVP

Page 7: Stacey GlobalConference Publication 2015ACCPISSUE1PTPv2

Sunday, October 18, 2015 • 7 ACCP GLOBAL CONFERENCE NEWS

New drugs have created more complexity when it comes to treating patients in a perioper-

ative setting. Patients with hemophilia have an increased risk of bleeding with surgical procedures. Patients with clot-ting disorders who are on lifelong anti-coagulation are at an increased risk of postoperative complications if their an-ticoagulation therapy is not reinitiated appropriately during the postoperative phases of care.

Navigating this delicate equilibrium often falls to the pharmacist before, during, and after surgery. The latest re-search and drugs will be the focus of the Perioperative Care PRN’s first fo-cus session, “Perioperative Care: Bal-ancing the Scales Between Bleeding and Clotting,” to be held at 1:30 p.m. Tuesday in Continental Ballroom 5.

“With the neuraxial and other anti-coagulation agents coming out, it has become more complex to treat pa-tients,” said Stacey Bortlik (Moultrie), Pharm.D., pediatric clinical pharma-cist, Department of Pharmacy Ser-vices, University of Florida Health - Shands Hospital and clinical assistant professor, University of Florida College of Pharmacy. Bortlik will moderate the session. “You may see more bleeding with elderly patients, or there may be an FDA-issued warning. We used to mainly have warfarin and it created the same complexity. But as pharma-cists, we were more hands-on and we would see those patients every month. Now, with the newer agents available and patients monitored less, there are more risks involved.”

The session will focus on three key areas: patients with hemophilia, new oral anticoagulants (NOACs), and pa-tients with neuraxial analgesics.

“Surgery itself can be high risk,” Bortlik said. “I want pharmacists to be comfortable with the practice itself and understand the different options. Pharmacists can be more apt to help the patients when they’re ambulato-ry or working in a surgical center and get a question from the physician, or in the emergency department where they need the information readily available. I want them to have the opportunity to say, ‘I know this. I have something from a session, from experts that I can use and I find is reliable.’”

Heidi Trinkman, Pharm.D., pediatric clinical pharmacy specialist, hematolo-gy/oncology and stem cell transplanta-tion, Cook Children’s Medical Center in Fort Worth, Texas, will discuss treating patients with hemophilia throughout the surgical process in the presentation “Management of Patients with Hemo-philia Throughout the Surgical Process.”

Trinkman will use case studies of

Perioperative Care PRN Session Explores Patient Bleeding Riskhigh-risk patients to discuss dosing and safety concerns. She also will re-view the hemostatic factor products available for use in the perioperative period.

Factor products are a particular challenge, especially because these agents have varying half-lives, dosing options, and stability. “The stability of the product is a concern and hemostat-ic factor products are very expensive,” Trinkman said. “When I have a patient that comes in, I ask myself, ‘What is the risk of bleed with the procedure and when was the factor product last

administered?’ And, as the patient is in surgery, I think about whether or not I want to prepare the factor product ahead of time and put it aside or wheth-er I should wait until the staff requests it, knowing that I will want to prepare it very quickly if needed.”

At the opposite end of the spectrum is patients at a risk of clotting, given

that perioperative care has become in-creasingly challenging now that warfa-rin has given way to the NOACs.

Edith A. Nutescu, Pharm.D., M.S., FCCP, associate professor, Department of Pharmacy Systems, Outcomes; policy director, Center for Pharmacoepidemi-ology & Pharmacoeconomic Research, College of Pharmacy; and codirector, Personalized Medicine Service, Univer-sity of Illinois Hospital & Health Sciences System in Chicago, will present “Novel Oral Anticoagulants and Their Place in the Surgical Spectrum.”

Her presentation will discuss how to assess the risk of hemorrhaging or de-veloping a venous thromboembolism (VTE) in the perioperative care setting. She will also review surgical guidelines for the urgent reversal of NOACs and analyze guideline controversies.

“Dr. Nutescu has done a lot of work in pharmacogenomics and is heavi-ly involved in anticoagulation,” Bortlik said.

Michael P. Gulseth, FASHP, Pharm.D., BCPS, program director for anticoagulation services, Department of Pharmaceutical Services, Sanford USD Medical Center in Sioux Falls, S.D., will explore the latest neuraxial anesthesia methods – primarily epidur-al or spinal – and tell how they differ from general anesthesia. His presen-tation, “Anticoagulation Considerations with Neuraxial Anesthesia,” will also preview upcoming ASRA (American Society of Regional Anesthesia and Pain Medicine) guidelines and discuss the latest direct oral anticoagulants (DOACs) and their interaction with neuraxial anesthesia, which can have potentially catastrophic consequences.

“Dr. Gulseth has been running an anticoagulation clinic for a good portion

“Surgery itself can be high risk. I want pharmacists to be

comfortable with the practice itself and understand the

different options. Pharmacists can be more apt to help the patients when they’re ambu-latory or working in a surgical

center and get a question from the physician, or in the

emergency department where they need the information

readily available.”

– Stacey Bortlik (Moultrie), Pharm.D.

of his career,” Bortlik said. “He has col-laborated with pharmacists and medi-cal practitioners, and wrote a point of care anticoagulation guide. Many clini-cians don’t have the natural knowledge or professional experience with this pa-tient population. If you work in a small hospital, you may rarely get a patient on a new anticoagulant who requires neuraxial analgesia.”

Helping demystify some of the new anticoagulants is important, Bortlik said. “I’m hoping that people will come away with the idea that medical care of patients like this isn’t scary. I want to people to feel that if they have a patient on an anticoagulant, that they have some basic information to help them. I want it to be the kind of session where people get a take-home message and retain some useful information; our overall goal of the session is to also decrease the fear of caring for patients with high-risk situations.”

“The stability of the product is a concern and hemostatic factor products are very expensive. When I have a

patient that comes in, I ask myself, ‘What is the risk of

bleed with the procedure and when was the factor product last administered?’ And, as

the patient is in surgery, I think about whether or not I want to prepare the factor product ahead of time and put it aside or whether I should wait until the staff requests it, knowing

that I will want to prepare it very quickly if needed.”

– Heidi Trinkman, Pharm.D.

Join the Twitter conversation! Share

meeting photos, news, and clinical insights

using #ACCPGC15 and you may win a prize

from ACCP!

Visit the On-Site Bookstore forYOUR BEST DEAL

on ACCP Publications

Skip the line and get the same discounts!Order at www.accp.com at any time before midnight Wednesday, Oct. 21.

Open daily at 7 a.m. near the Registration Desk and Cyber Café in the Hilton San Francisco Union Square.

Order any publication and receive:• Our lowest price (member price)• FREE SHIPPING AND HANDLING to any address in the continental U.S.• Shipping and handling discounts of 75% on orders shipped to other

locations*

*Shipping discount not available on PSAP full series Print Packages.

Page 8: Stacey GlobalConference Publication 2015ACCPISSUE1PTPv2

8 • Sunday, October 18, 2015 ACCP GLOBAL CONFERENCE NEWS

ParkerContinued from page 1

2016-2018 Series of ACCP Self-Assessment Programs for Specialty Recertification

Ambulatory Care Self-Assessment Program

(ACSAP)The nine books in the 2016-2018 series a re Endocr ino log ic /Rheumato log ic Care, Dermato log ic Care, In fect ion Primary Care, Oncologic/Hematologic Ca re , Neuro log ic /Psy ch ia t r i c Care Fluids and Nutrition/GI Care, Cardiologic Care, Women’s and Men’s Care, and Nephrologic/Geriatric Care.

Critical Care Self-Assessment Program

(CCSAP) The nine books in the 2016-2018 series are Infection Critical Care, Medication Administration/Critical Care Research, Pain and Sedation/Support and Preven-tion, Cardiology Critical Care, Renal/Pulmonary Critical Care, Neurocritical Care/IC Technology, Medical Issues in the ICU, Toxicology/Practice Issues, and Fluids and Electrolytes/Hepatic Care/ GI Care.

Pediatric Self-Assessment Program

(PedSAP)The eight books In the 2016-2018 series are Immunology, Pediatric Critical Care, Research Ethics/Study Design, Pediatric Emergencies, Sedation and Analgesia, Pediatric Oncology, Fluids/Electrolytes/ Nutrition, and Neonatal and Pediatric Sepsis.

Pharmacotherapy Self-Assessment Program

(PSAP)The nine books in the 2016-2018 series are Cardiology, GI/Fluids and Nutrition, Women’s and Men’s Health, Endocri-no logy/Nephrology, Pulmonary and Emergency Medicine, Pediatrics/Geriat-rics, Infectious Diseases, Hematology/Immunology/Oncology, and Neurology/Psychiatry.

NOW AVAILABLE FOR PURCHASE!

Betty J. Dong, Pharm.D., FCCP, FASHP, FAPHA, AAHIVP

David P. Elliott, Pharm.D., FCCP, FASCP, CGP, AGSF

Series Editors

Bradley A. Boucher, Pharm.D., FCCP, BCPS, MCCM

Curtis E. Haas, Pharm.D., FCCP, BCPS

Series Editors

Marcia L. Buck, Pharm.D., FCCP, FPPAG

Kalen B. Manasco, Pharm.D., BCPS

Series Editors

John Murphy, Pharm.D., FCCP, FASHP

Mary Lee, Pharm.D., FCCP, BCPS

Series Editors

Selection Committee commented that Dr. Talbert’s name “is nearly synony-mous with clinical pharmacy practice.” The committee added:

“Dr. Talbert has pioneered many in-novative practice models and achieved recognition not only by our profession but also by medicine and other health care disciplines. He is recognized as an outstanding mentor and has trained many clinical pharmacists who’ve gone on themselves to become outstand-ing clinical pharmacists. His record of scholarly achievement is clearly out-standing and he is well-known for his kind and untiring mentorship of clinical pharmacists who have followed in his footsteps.”

Dr. Talbert has served as member and chair of numerous ACCP com-mittees and task forces, the ACCP Board of Regents (1998–1991), the ACCP Research Institute Board of Trustees, and the Pharmacotherapy Board of Directors and as ACCP pres-ident (1992–1993). His many awards include the University of Texas Col-lege of Pharmacy Preceptor of the Year Award, the Robert G. Leonard Memorial Lecture Award from the Uni-versity of Texas at Austin, the Robert K. Chalmers Distinguished Pharmacy Educator Award from the American Association of Colleges of Pharma-cy, the ACCP Russell R. Miller Award, and the ACCP Education Award. He was elected as an ACCP Fellow in 1986 and as a fellow of the American

Heart Association in 2008.The Paul F. Parker Medal recogniz-

es outstanding and sustained contri-butions to the profession that improve patient or service outcomes, create innovative practices, affect populations of patients, further the professional role of pharmacists, or expand the recog-nition of pharmacists as health profes-sionals. Paul Parker was one of clinical pharmacy’s most influential propo-nents. Before his death in 1998, Parker spent 24 years as director of pharmacy at the University of Kentucky Chandler Medical Center in Lexington, Kentucky. His innovations include developing de-centralized pharmacy services, placing pharmacists in the hospital’s clinical areas, and developing the nation’s first pharmacist-staffed drug information center. Parker’s vision for pharmacy practice was passed along to the more than 150 residents and fellows who trained in the Kentucky program during his tenure, many of whom are leaders in clinical pharmacy today.

“Dr. Talbert has pioneered many innovative practice models and

achieved recognition not only by our profession but also by

medicine and other health care disciplines. His record of

scholarly achievement is clearly outstanding and he is well-known for his kind and untiring mentor-ship of clinical pharmacists who have followed in his footsteps.”

Members of the EMED PRN in-vite all attendees to join them for “Professor Walk Rounds”

of the Scientific Poster Presentations. Emergency medicine faculty and

experts will exchange ideas and commentary with authors of posters whose content is relevant to this area of practice.

Rounds will begin at the start of each poster session, with tour groups meeting up next to the stage. Group leaders, by session will be:

Prospective candidates will gather at 8 a.m. today outside Golden Gates 6–8 to submit an early bid

for highly coveted 2016–2017 residen-cy and fellowship positions.

More than 300 applicants have reg-istered for the chance to meet face-to-face with the preceptors and program directors of some of pharmacy’s most highly acclaimed programs. This year’s Forum offers three such opportunities: (1) Residency and Fellowship I (8–10 a.m.); (2) Residency and Fellowship II (10–11:30 a.m.) and (3) Residency, Fellowship, and Career Recruitment (1–2:30 p.m.).

The afternoon forum allows clinical faculty and practitioners who are pursu-ing new employment opportunities the

Morning Forums DrawingCandidates Nationwide

chance to connect with recruiting hospi-tals and academic institutions. Interest-ed attendees are encouraged to interact with the representatives of leading hos-pitals and academic institutions, learn more about national and international employment opportunities, and broad-en their network.

For more information, visit www.accp.com/forum15.

• Session I (1–2:30 p.m. Sunday) Frank Paloucek• Session II (3:30–5 p.m. Sunday) Megan Musselman• Session III (11:30 a.m.– 1:15 p.m. Monday) Asad Patanwala• Session IV (8–10 a.m. Tuesday) Nicole Acquisto• Special Research in Progress Session (noon–1:30 p.m. Tuesday) Mary Beth Shirk• Session V (7:30–9:30 a.m. Wednesday) Mason Bucklin

PRN Schedules Poster Rounds

Residency and Fellowship I:8–10 a.m.

Residency and Fellowship II:10–11:30 a.m.

Residency, Fellowship, and Career Recruitment:

1–2:30 p.m.